List view / Grid view
30 March 2015 | By Victoria White
A new trial of the drug Abatacept could bring hope to the millions of Britons who are likely to one day suffer from rheumatoid arthritis...
30 March 2015 | By Victoria White
Cellectis has announced the pricing of its initial public offering of 5,500,000 ADSs at a price to the public of $41.50 per ADS...
27 March 2015 | By Victoria White
PHE scientists are heading a consortium researching a rapid ‘in the field’ Ebola test, following the successful award of IMI funding...
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
26 March 2015 | By Victoria White
Taconic and Cellaria have entered into a scientific collaboration to facilitate use of patient-derived xenografts in animal models for oncology research...
26 March 2015 | By Victoria White
New treatments, diagnostics and medical technologies are set to benefit from an investment of £32 million through the Biomedical Catalyst...
25 March 2015 | By Victoria White
AstraZeneca to collaborate with the HSCI to adapt a technique that creates human beta cells from stem cells to search for new treatments for diabetes...
25 March 2015 | By Victoria White
Cancer Research UK has partnered with the EPSRC to co-fund multidisciplinary research projects with up to £37.5m in funding available over five years...
24 March 2015 | By Victoria White
Semma, a company developing cell therapy for T1D, announces that it has closed a $44 million Series A consisting of equity financing and strategic funding...
24 March 2015 | By Victoria White
Bristol-Myers Squibb acquires license from Novo Nordisk for a discovery biologics research programme focused on modulating the innate immune system...
24 March 2015 | By Victoria White
Rigontec, a company developing RNA-based immunotherapeutics, today announces it has raised €4.8 million in a second closing of its Series A financing round...
23 March 2015 | By Victoria White
A blood test that measures the number of prostate tumour cells shed into the bloodstream can act as an early warning sign that treatment is not working...
23 March 2015 | By Victoria White
Confluence and AOP have signed an agreement to co-develop and market a product for the treatment of Fragile X Syndrome in Europe and the Middle East...
20 March 2015 | By Victoria White
ExpreS2ion Biotechnologies announce the release by its partners at University of Copenhagen of a vaccine against placental malaria for testing in humans...
20 March 2015 | By Victoria White
Probiodrug has announced that the company will present data on its specific pGlu-Abeta mouse antibody 17/1 at AD/PDTM 2015 in Nice, France...
